These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17108987)

  • 1. New approaches to molecular cancer therapeutics.
    Collins I; Workman P
    Nat Chem Biol; 2006 Dec; 2(12):689-700. PubMed ID: 17108987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular underpinnings of the targeted therapy for cancer.
    Wcisło G
    Acta Pol Pharm; 2008; 65(6):633-40. PubMed ID: 19172844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical approaches to the discovery and development of cancer therapies.
    Neidle S; Thurston DE
    Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of molecular cancer therapeutics.
    van Montfort RL; Workman P
    Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to develop a successful cancer drug--molecules to medicines or targets to treatments?
    Newell DR
    Eur J Cancer; 2005 Mar; 41(5):676-82. PubMed ID: 15763642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Front-line drug discovery system for cancer].
    Mizukami T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development.
    Hermiston TW; Kirn DH
    Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics.
    Workman P
    Cold Spring Harb Symp Quant Biol; 2005; 70():499-515. PubMed ID: 16869789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contemporary drug development process: advances and challenges in preclinical and clinical development.
    Garrett MD; Walton MI; McDonald E; Judson I; Workman P
    Prog Cell Cycle Res; 2003; 5():145-58. PubMed ID: 14593708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cell-based genomic and small molecule screens.
    Caldwell JS
    Adv Cancer Res; 2007; 96():145-73. PubMed ID: 17161679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules, big players: the National Cancer Institute's Initiative for Chemical Genetics.
    Tolliday N; Clemons PA; Ferraiolo P; Koehler AN; Lewis TA; Li X; Schreiber SL; Gerhard DS; Eliasof S
    Cancer Res; 2006 Sep; 66(18):8935-42. PubMed ID: 16982730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemogenomics approaches to novel target discovery.
    Gaither LA
    Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond genomics.
    Dollery CT
    Clin Pharmacol Ther; 2007 Oct; 82(4):366-70. PubMed ID: 17851575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
    Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
    Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the outcomes: developing cancer therapeutics.
    Utku N
    Future Oncol; 2012 Jan; 8(1):87-103. PubMed ID: 22149037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.